NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and NetBio said on Monday they will commercialize new products for DNA sample collection and analysis for the forensics market.
The partnership allies the global distribution reach and sample collection capabilities of GE Healthcare Life Sciences, a business unit of GE Healthcare, with NetBio's DNA analysis technologies. The deal will result in products that make DNA fingerprinting easier and quicker than with current methods, the partners said.
James Schumm, vice president of molecular biology for NetBio, said that his firm's technology combines a large number of complex DNA process steps "into a fully automated, fully integrated system for rapid DNA analysis."
DNA analysis has revolutionized forensics, he added, and "partnering with GE Healthcare has the potential to accelerate the pace of this revolution by commercializing products that will provide law enforcement agencies and forensic laboratories with faster results."
Financial and other terms of the deal were not disclosed.